vs
FIRST CITIZENS BANCSHARES INC（FCNCA）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
FIRST CITIZENS BANCSHARES INC的季度营收约是Royalty Pharma plc的1.7倍（$1.1B vs $622.0M），FIRST CITIZENS BANCSHARES INC净利率更高（49.1% vs 34.4%，领先14.7%），Royalty Pharma plc同比增速更快（4.8% vs 3.5%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -33.5%）
第一公民银行控股公司是美国本土银行控股企业，总部位于罗德岛州普罗维登斯，旗下拥有国民公民银行，业务覆盖美国康涅狄格、特拉华、佛罗里达、马里兰、马萨诸塞、密歇根、新罕布什尔、新泽西、纽约、俄亥俄、宾夕法尼亚、罗德岛、佛蒙特、弗吉尼亚等14个州及华盛顿哥伦比亚特区。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FCNCA vs RPRX — 直观对比
营收规模更大
FCNCA
是对方的1.7倍
$622.0M
营收增速更快
RPRX
高出1.3%
3.5%
净利率更高
FCNCA
高出14.7%
34.4%
两年增速更快
RPRX
近两年复合增速
-33.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $534.0M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 49.1% | 34.4% |
| 营收同比 | 3.5% | 4.8% |
| 净利润同比 | 10.6% | 2.9% |
| 每股收益（稀释后） | $42.63 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCNCARPRX
| Q1 26 | $1.1B | — | ||
| Q4 25 | $2.4B | $622.0M | ||
| Q3 25 | $2.4B | $609.3M | ||
| Q2 25 | $2.4B | $578.7M | ||
| Q1 25 | $2.3B | $568.2M | ||
| Q4 24 | $2.4B | $593.6M | ||
| Q3 24 | $2.4B | $564.7M | ||
| Q2 24 | $2.5B | $537.3M |
净利润FCNCARPRX
| Q1 26 | $534.0M | — | ||
| Q4 25 | $580.0M | $214.2M | ||
| Q3 25 | $568.0M | $288.2M | ||
| Q2 25 | $575.0M | $30.2M | ||
| Q1 25 | $483.0M | $238.3M | ||
| Q4 24 | $700.0M | $208.2M | ||
| Q3 24 | $639.0M | $544.0M | ||
| Q2 24 | $707.0M | $102.0M |
营业利润率FCNCARPRX
| Q1 26 | — | — | ||
| Q4 25 | 33.3% | 62.4% | ||
| Q3 25 | 30.9% | 70.1% | ||
| Q2 25 | 31.9% | 36.3% | ||
| Q1 25 | 28.3% | 94.0% | ||
| Q4 24 | 30.6% | 60.9% | ||
| Q3 24 | 35.7% | — | ||
| Q2 24 | 39.8% | 50.2% |
净利率FCNCARPRX
| Q1 26 | 49.1% | — | ||
| Q4 25 | 23.8% | 34.4% | ||
| Q3 25 | 23.3% | 47.3% | ||
| Q2 25 | 24.2% | 5.2% | ||
| Q1 25 | 21.0% | 41.9% | ||
| Q4 24 | 29.1% | 35.1% | ||
| Q3 24 | 26.1% | 96.3% | ||
| Q2 24 | 28.7% | 19.0% |
每股收益（稀释后）FCNCARPRX
| Q1 26 | $42.63 | — | ||
| Q4 25 | $45.33 | $0.49 | ||
| Q3 25 | $43.08 | $0.67 | ||
| Q2 25 | $42.36 | $0.07 | ||
| Q1 25 | $34.47 | $0.55 | ||
| Q4 24 | $49.19 | $0.46 | ||
| Q3 24 | $43.42 | $1.21 | ||
| Q2 24 | $47.54 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | $34.0B | $9.0B |
| 股东权益账面价值 | $22.0B | $9.7B |
| 总资产 | $236.0B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.54× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FCNCARPRX
| Q1 26 | — | — | ||
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B |
总债务FCNCARPRX
| Q1 26 | $34.0B | — | ||
| Q4 25 | $35.8B | $9.0B | ||
| Q3 25 | $38.3B | $8.9B | ||
| Q2 25 | $37.6B | $8.0B | ||
| Q1 25 | $38.0B | $7.6B | ||
| Q4 24 | $36.7B | $7.6B | ||
| Q3 24 | $36.8B | $7.6B | ||
| Q2 24 | $37.1B | $7.6B |
股东权益FCNCARPRX
| Q1 26 | $22.0B | — | ||
| Q4 25 | $22.2B | $9.7B | ||
| Q3 25 | $22.0B | $9.6B | ||
| Q2 25 | $22.3B | $9.5B | ||
| Q1 25 | $22.3B | $9.8B | ||
| Q4 24 | $22.2B | $10.3B | ||
| Q3 24 | $22.8B | $10.3B | ||
| Q2 24 | $22.5B | $9.8B |
总资产FCNCARPRX
| Q1 26 | $236.0B | — | ||
| Q4 25 | $229.7B | $19.6B | ||
| Q3 25 | $233.5B | $19.3B | ||
| Q2 25 | $229.7B | $18.3B | ||
| Q1 25 | $228.8B | $17.6B | ||
| Q4 24 | $223.7B | $18.2B | ||
| Q3 24 | $220.6B | $18.0B | ||
| Q2 24 | $219.8B | $17.7B |
负债/权益比FCNCARPRX
| Q1 26 | 1.54× | — | ||
| Q4 25 | 1.61× | 0.92× | ||
| Q3 25 | 1.74× | 0.93× | ||
| Q2 25 | 1.69× | 0.84× | ||
| Q1 25 | 1.70× | 0.78× | ||
| Q4 24 | 1.65× | 0.74× | ||
| Q3 24 | 1.61× | 0.74× | ||
| Q2 24 | 1.65× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FCNCARPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $827.1M | ||
| Q3 25 | $916.0M | $702.6M | ||
| Q2 25 | $859.0M | $364.0M | ||
| Q1 25 | $98.0M | $596.1M | ||
| Q4 24 | $1.1B | $742.5M | ||
| Q3 24 | $991.0M | $703.6M | ||
| Q2 24 | $417.0M | $658.2M |
自由现金流FCNCARPRX
| Q1 26 | — | — | ||
| Q4 25 | $807.0M | — | ||
| Q3 25 | $678.0M | — | ||
| Q2 25 | $733.0M | — | ||
| Q1 25 | $-5.0M | — | ||
| Q4 24 | $991.0M | — | ||
| Q3 24 | $885.0M | — | ||
| Q2 24 | $316.0M | — |
自由现金流率FCNCARPRX
| Q1 26 | — | — | ||
| Q4 25 | 33.1% | — | ||
| Q3 25 | 27.9% | — | ||
| Q2 25 | 30.9% | — | ||
| Q1 25 | -0.2% | — | ||
| Q4 24 | 41.2% | — | ||
| Q3 24 | 36.2% | — | ||
| Q2 24 | 12.8% | — |
资本支出强度FCNCARPRX
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | — | ||
| Q3 25 | 9.8% | — | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 4.1% | — |
现金转化率FCNCARPRX
| Q1 26 | — | — | ||
| Q4 25 | 1.81× | 3.86× | ||
| Q3 25 | 1.61× | 2.44× | ||
| Q2 25 | 1.49× | 12.06× | ||
| Q1 25 | 0.20× | 2.50× | ||
| Q4 24 | 1.60× | 3.57× | ||
| Q3 24 | 1.55× | 1.29× | ||
| Q2 24 | 0.59× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCNCA
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
